BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,219,000 | -18.3% | 21,291 | -21.3% | 0.03% | -6.5% |
| Q2 2022 | $3,941,000 | +37.3% | 27,045 | +11.7% | 0.03% | +82.4% |
| Q1 2022 | $2,871,000 | -14.6% | 24,219 | -0.7% | 0.02% | -5.6% |
| Q4 2021 | $3,362,000 | +27.9% | 24,398 | +28.9% | 0.02% | +12.5% |
| Q3 2021 | $2,628,000 | +12.5% | 18,921 | -21.3% | 0.02% | +14.3% |
| Q2 2021 | $2,335,000 | +21.6% | 24,052 | -14.4% | 0.01% | +7.7% |
| Q1 2021 | $1,920,000 | -13.1% | 28,095 | +9.0% | 0.01% | -7.1% |
| Q4 2020 | $2,210,000 | – | 25,783 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |